Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721

Watchlist Manager
Xinjiang Bai Hua Cun Pharma Tech Co Ltd Logo
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Watchlist
Price: 9.92 CNY -9.98% Market Closed
Market Cap: 3.8B CNY

Gross Margin
Xinjiang Bai Hua Cun Pharma Tech Co Ltd

51.8%
Current
44%
Average
18.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51.8%
=
Gross Profit
204m
/
Revenue
393.7m

Gross Margin Across Competitors

No Stocks Found

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View

Market Cap
3.8B CNY
Industry
Metals & Mining

Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.

Intrinsic Value
3.17 CNY
Overvaluation 68%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51.8%
=
Gross Profit
204m
/
Revenue
393.7m
What is the Gross Margin of Xinjiang Bai Hua Cun Pharma Tech Co Ltd?

Based on Xinjiang Bai Hua Cun Pharma Tech Co Ltd's most recent financial statements, the company has Gross Margin of 51.8%.

Back to Top